CMH but not its inactive analog 4-(4-chloro-2-methylphenoxy)-N-(3-ethoxypropyl) butanamide (CMB) (6094911) was further shown to downregulate c-FLIPL and c-FLIPS levels in MCF-7 cancer cells [31]. The gene discussed is CFLAR; the disease is cancer.